Searched for
LAURUS LABS EARNINGS
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...- Nifty stuck in a range but small and midcaps are where real money is being made: Ashish ChaturmohtaIndian stock markets may appear stagnant, but opportunities exist in small and midcap stocks. JM Financial's Ashish Chaturmohta highlights ...
- Rising bond yields, oil prices keeping markets on edge; selective bets still emerging: Pankaj PandeyGlobal markets are under pressure due to rising bond yields and geopolitical tensions. Higher crude oil prices are a key concern, potential...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Crorepati investors splurge $1 billion to buy these 10 stocks. Should you follow the smart money?Wealthy investors are making significant moves, pouring over $1 billion into ten select stocks. This concentrated buying occurs even as the...
- Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...
- Laurus Labs Q4 Results: Cons PAT increased 19% to Rs 279 crore, revenue rises 5%Laurus Labs reported a 19% year-on-year jump in net profit to Rs 279 crore for the March quarter, with revenue rising 5% to Rs 1,812 crore....
- Laurus Labs shares tumble 4% despite 886% surge in Q2 PAT. Should you buy the dip?Laurus Labs shares fell despite Q2FY26 PAT surging 886% to Rs 195 crore, revenue rising 35%, and EBITDA more than doubling, with margins ex...
- Laurus Labs shares crash 10% after missing Q3 estimatesIn Q3, the company's revenue dropped 23% year-on-year (YoY) at Rs 1,195 crore while profit also dropped 89% YoY to Rs 23 crore.
- Laurus Labs Q2 Results: Net profit nosedives 84% YoY to Rs 37 croreLaurus Labs' revenue for the quarter ended September declined 22.3% YoY to Rs 1,224 crore in Q2FY24. The company's earnings before interest...
- Laurus Labs Q3 Results: Net profit rises 32% to Rs 203 croreDr. Satyanarayana Chava, founder and chief executive officer of Laurus Labs said the company is on path of diversification and strengthenin...
- Laurus Labs Q3 results: Net profit drops 44% YoY to Rs 154 croreThe earnings before interest, tax, depreciation and amortization (EBITDA) decreased 17% YoY to Rs 290 crore. The EBITDA margins dropped by ...
- Buy Laurus Labs, target price Rs 800: Motilal OswalLaurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 35388.93 Crore) operating in Pharmaceutica...
- Buy Laurus Labs, target price Rs 800: Motilal OswalLaurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 36448.72 Crore) operating in Pharmaceutica...
- Laurus Labs Q3 results: Net profit zooms nearly 4-fold to Rs 273 crThe company had posted a net profit of Rs 73.47 crore for the corresponding period of the previous fiscal, Laurus Labs said in a filing to ...
- Laurus Labs Q2 results: Net profit jumps over four-fold to Rs 242.27 crConsolidated revenue from operations of the company stood at Rs 1,138.84 crore for the quarter under consideration. It was Rs 712.42 crore ...
- Trending stocks: Laurus Labs shares surge over 15%A total of 623,838 shares changed hands on the counter till 01:29PM (IST).
- Buy Laurus Labs, target Rs 470: Motilal Oswal SecuritiesBuy Laurus Labs at a price target of Rs 470.
- Laurus Labs hopes better profits in Q4 with lower interest outgo after debt retirementThe company repaid long term loans of Rs 226.3 crore from the proceeds of Rs 1,332 crore raised through an initial public offering (IPO) in...
Load More
